ArriVent BioPharma, Inc.

Ownership Transactions Reported by 13 Insiders

Industry
Pharmaceutical Preparations
Location
18 Campus Blvd., Suite 100, Newtown Square, Pennsylvania

There are no Buy or Sell transactions made by insiders since 7/8/2023

ArriVent BioPharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Kristine Peterson Director Apr 22, 2024
L. Gordon Director, 10%+ Owner Jan 30, 2024
James Healy Director Jan 30, 2024
James Paul Kastenmayer General Counsel Jan 25, 2024
Winston Kung Chief Financial Officer Jan 25, 2024
Robin LaChapelle Chief Operating Officer Jan 25, 2024
Stuart Lutzker President of R&D, Director Jan 25, 2024
Chris Nolet Director Jan 25, 2024
Zhengbin Yao President and CEO, Director Jan 25, 2024
Orbimed Advisors Llc Director, 10%+ Owner Jan 30, 2024
Hillhouse Investment Management, Ltd. 10%+ Owner Jan 30, 2024
Bahija Jallal Director Jan 25, 2024
John Hohneker Director May 16, 2024

Recent Insider Transactions by Companies or Individuals for ArriVent BioPharma, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership